Navigating GLP-1 Medications with Confidence
GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Zepbound have transformed the treatment landscape for type 2 diabetes and chronic weight management. Whether you are just starting your first injection or stepping up to a higher dose, staying informed is one of the most important things you can do for long-term success. The Jabby blog exists to help you do exactly that.
Our articles are written with real patients in mind. We break down complex medical topics into clear, actionable advice so you can track your progress with confidence. From understanding how semaglutide differs from tirzepatide to building a daily side-effect log, every guide is designed to complement your care team's guidance with practical tools you can use right away.
Medication Comparisons
Head-to-head breakdowns of Mounjaro, Ozempic, Wegovy, and more.
Tracking Guides
Step-by-step advice for logging injections, weight, and side effects.
Side-Effect Management
Recognise patterns, escalate concerns, and stay on course.
Dose Escalation
What to expect at each dose level and when to talk to your doctor.
Not sure where to start? Our Mounjaro vs Ozempic vs Wegovy comparison is the most popular article on the blog and a great introduction to the three leading GLP-1 treatments. If you already know which medication you are on, jump straight to a medication-specific guide such as our semaglutide tracking guide or the Mounjaro progress tracker.
For a broader look at why dedicated injection tracking matters, read What is the Best App for Tracking My GLP-1 Progress? It covers the core metrics every patient should monitor regardless of which GLP-1 they take, including adherence streaks, symptom frequency, and weight trends over time.
Frequently Asked Questions
What topics does the Jabby blog cover?
The Jabby blog covers GLP-1 medication guides for Ozempic, Mounjaro, Wegovy, and Zepbound, including injection tracking tips, side-effect management, dose-escalation timelines, and head-to-head medication comparisons. Each article is written to help patients and caregivers make informed decisions about their therapy.
How can I track my GLP-1 medication progress?
You can track GLP-1 progress by logging every injection, recording side effects as they occur, monitoring weight trends week over week, and reviewing analytics over time. The Jabby GLP-1 weight-loss tracker provides a dedicated dashboard for all GLP-1 receptor agonists, including both semaglutide and tirzepatide medications, so everything lives in one place.
What is the difference between Mounjaro, Ozempic, and Wegovy?
Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, while Ozempic and Wegovy both contain semaglutide, a single-target GLP-1 receptor agonist. Ozempic is FDA-approved for type 2 diabetes, whereas Wegovy is approved specifically for chronic weight management. Read our detailed comparison of Mounjaro, Ozempic, and Wegovy for a full breakdown of effectiveness, side effects, and costs.
How often is the Jabby blog updated?
The Jabby blog is updated regularly with new GLP-1 guides, tracking tips, and medication comparisons. New articles are published as treatment guidelines evolve and new clinical research becomes available, so check back often for the latest insights.
Does Jabby support tracking for semaglutide and tirzepatide?
Yes. Jabby supports tracking for all semaglutide-based medications (Ozempic, Wegovy, Rybelsus) and all tirzepatide-based medications (Mounjaro, Zepbound). You can log doses, set injection-day reminders, and track side effects for any GLP-1 therapy. Learn more in our guides on tracking tirzepatide injections and tracking semaglutide progress.